CAR T-cell therapy tricks cancer cells with decoy, increases treatment efficiency in B-cell acute lymphoblastic leukemia
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
AZoLifeSciences on MSN1d
How B Cells Know When to Mutate—and When to Chill
Study reveals B cells suppress mutations during rapid division, enhancing immune response and offering critical insights for ...
News Medical on MSN3d
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors
B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...
Abundance of key immune cells may be influenced by estrogen and XX chromosomes
Women have a higher proportion of key immune cells between puberty and menopause, which may be linked to the sex hormone ...
National Geographic news1y
The Stem Cell Divide
In the beginning, one cell becomes two, and two become four. Being fruitful, they multiply into a ball of many cells, a shimmering sphere of human potential. Scientists have long dreamed of ...
National Academies of Sciences%2c Engineering%2c and Medicine7mon
Guidelines for Human Embryonic Stem Cell Research
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
FOX40 News1mon
Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I ™), today announced a licensing agreement ...